Eckert & Ziegler Strahlen und Medizintechnik AG
F:EUZ

Watchlist Manager
Eckert & Ziegler Strahlen und Medizintechnik AG Logo
Eckert & Ziegler Strahlen und Medizintechnik AG
F:EUZ
Watchlist
Price: 15.59 EUR -1.64% Market Closed
Market Cap: 325m EUR

Net Margin

13.1%
Current
Improving
by 1.4%
vs 3-y average of 11.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.1%
=
Net Income
€39.8m
/
Revenue
€304.5m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
13.1%
=
Net Income
€39.8m
/
Revenue
€304.5m

Peer Comparison

Country Company Market Cap Net
Margin
DE
Eckert & Ziegler Strahlen und Medizintechnik AG
XETRA:EUZ
959.9m EUR
Loading...
US
Abbott Laboratories
NYSE:ABT
210.8B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
186.6B USD
Loading...
US
Stryker Corp
NYSE:SYK
138B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.3B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
128B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58.7B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
48.8B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.7B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49.3B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...
No Stocks Found

Market Distribution

Higher than 87% of companies in Germany
Percentile
87th
Based on 3 835 companies
87th percentile
13.1%
Low
-222 027.4% — -2%
Typical Range
-2% — 6%
High
6% — 85 055.6%
Distribution Statistics
Germany
Min -222 027.4%
30th Percentile -2%
Median 2.2%
70th Percentile 6%
Max 85 055.6%

Eckert & Ziegler Strahlen und Medizintechnik AG
Glance View

Eckert & Ziegler Strahlen- und Medizintechnik AG engages in the provision of isotope technology for medical, scientific, and industrial use. The company is headquartered in Berlin, Berlin and currently employs 866 full-time employees. The company went IPO on 2008-02-25. The firm operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

EUZ Intrinsic Value
20.04 EUR
Undervaluation 22%
Intrinsic Value
Price
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
13.1%
=
Net Income
€39.8m
/
Revenue
€304.5m
What is Eckert & Ziegler Strahlen und Medizintechnik AG's current Net Margin?

The current Net Margin for Eckert & Ziegler Strahlen und Medizintechnik AG is 13.1%, which is above its 3-year median of 11.7%.

How has Net Margin changed over time?

Over the last 3 years, Eckert & Ziegler Strahlen und Medizintechnik AG’s Net Margin has decreased from 13.4% to 13.1%. During this period, it reached a low of 10.6% on Sep 30, 2024 and a high of 13.4% on Sep 30, 2022.

Back to Top